RVMD CIK: 1628171

Revolution Medicines, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
billions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.19
FY22:
−0.26
FY23:
−0.49
FY24:
−0.69
FY25:
−1.18
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.18
FY22:
−0.24
FY23:
−0.43
FY24:
−0.68
FY25:
−1.08
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.19
FY22:
−0.25
FY23:
−0.44
FY24:
−0.60
FY25:
−1.13
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.19
FY22:
−0.25
FY23:
−0.44
FY24:
−0.60
FY25:
−1.13

All amounts in billions USD Data sources:SEC EDGARTwelve Data